Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

PTX3 is a component of the humoral arm of innate immunity and an extrinsic oncosuppressor gene taming tumor-promoting inflammation. Here, we show that two enhancers differently regulate PTX3 expression: enhancer 1, located 230 kb upstream of PTX3 promoter, mediated the action of inflammatory transcription factors; and enhancer 2, encompassing PTX3 second exon, was implicated in pre-initiation complex assembly. Polycomb repressive complex 2 silenced these regulatory elements and the promoter in basal condition. Enhancer 1 was epigenetically inactivated in early colorectal cancer (CRC) stages, while the promoter and enhancer 2 showed increasingly DNA methylation during CRC progression from adenomas to stage II and III CRC. Inhibition of DNA methylation rescued PTX3 expression in CRC. Finally, enhancer 1 acquired the binding of STAT3 in stage I CRC, and inhibition of STAT3 phosphorylation restored PTX3 activity and decreased enhancer 1 methylation. Thus, the expression of PTX3 is under the control of two enhancers, which emerge as important fine regulators of PTX3 expression in inflammation and cancer.

Original languageEnglish
Article numbere1333215
JournalOncoImmunology
Volume6
Issue number7
DOIs
Publication statusPublished - Jul 3 2017

Fingerprint

Epigenomics
Colorectal Neoplasms
Inflammation
Genes
DNA Methylation
Neoplasms
Polycomb Repressive Complex 2
Innate Immunity
Adenoma
Methylation
Exons
Transcription Factors
Phosphorylation

Keywords

  • Cancer
  • DNA methylation
  • enhancer
  • inflammation
  • pentraxin-3

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this

@article{71bb5081d0694f48a5d32ca13d9b815f,
title = "Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer",
abstract = "PTX3 is a component of the humoral arm of innate immunity and an extrinsic oncosuppressor gene taming tumor-promoting inflammation. Here, we show that two enhancers differently regulate PTX3 expression: enhancer 1, located 230 kb upstream of PTX3 promoter, mediated the action of inflammatory transcription factors; and enhancer 2, encompassing PTX3 second exon, was implicated in pre-initiation complex assembly. Polycomb repressive complex 2 silenced these regulatory elements and the promoter in basal condition. Enhancer 1 was epigenetically inactivated in early colorectal cancer (CRC) stages, while the promoter and enhancer 2 showed increasingly DNA methylation during CRC progression from adenomas to stage II and III CRC. Inhibition of DNA methylation rescued PTX3 expression in CRC. Finally, enhancer 1 acquired the binding of STAT3 in stage I CRC, and inhibition of STAT3 phosphorylation restored PTX3 activity and decreased enhancer 1 methylation. Thus, the expression of PTX3 is under the control of two enhancers, which emerge as important fine regulators of PTX3 expression in inflammation and cancer.",
keywords = "Cancer, DNA methylation, enhancer, inflammation, pentraxin-3",
author = "Marcello Rubino and Paolo Kunderfranco and Gianluca Basso and Greco, {Carolina Magdalen} and Fabio Pasqualini and Simone Serio and Massimo Roncalli and Luigi Laghi and Alberto Mantovani and Roberto Papait and Cecilia Garlanda",
year = "2017",
month = "7",
day = "3",
doi = "10.1080/2162402X.2017.1333215",
language = "English",
volume = "6",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Taylor and Francis Inc.",
number = "7",

}

TY - JOUR

T1 - Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer

AU - Rubino, Marcello

AU - Kunderfranco, Paolo

AU - Basso, Gianluca

AU - Greco, Carolina Magdalen

AU - Pasqualini, Fabio

AU - Serio, Simone

AU - Roncalli, Massimo

AU - Laghi, Luigi

AU - Mantovani, Alberto

AU - Papait, Roberto

AU - Garlanda, Cecilia

PY - 2017/7/3

Y1 - 2017/7/3

N2 - PTX3 is a component of the humoral arm of innate immunity and an extrinsic oncosuppressor gene taming tumor-promoting inflammation. Here, we show that two enhancers differently regulate PTX3 expression: enhancer 1, located 230 kb upstream of PTX3 promoter, mediated the action of inflammatory transcription factors; and enhancer 2, encompassing PTX3 second exon, was implicated in pre-initiation complex assembly. Polycomb repressive complex 2 silenced these regulatory elements and the promoter in basal condition. Enhancer 1 was epigenetically inactivated in early colorectal cancer (CRC) stages, while the promoter and enhancer 2 showed increasingly DNA methylation during CRC progression from adenomas to stage II and III CRC. Inhibition of DNA methylation rescued PTX3 expression in CRC. Finally, enhancer 1 acquired the binding of STAT3 in stage I CRC, and inhibition of STAT3 phosphorylation restored PTX3 activity and decreased enhancer 1 methylation. Thus, the expression of PTX3 is under the control of two enhancers, which emerge as important fine regulators of PTX3 expression in inflammation and cancer.

AB - PTX3 is a component of the humoral arm of innate immunity and an extrinsic oncosuppressor gene taming tumor-promoting inflammation. Here, we show that two enhancers differently regulate PTX3 expression: enhancer 1, located 230 kb upstream of PTX3 promoter, mediated the action of inflammatory transcription factors; and enhancer 2, encompassing PTX3 second exon, was implicated in pre-initiation complex assembly. Polycomb repressive complex 2 silenced these regulatory elements and the promoter in basal condition. Enhancer 1 was epigenetically inactivated in early colorectal cancer (CRC) stages, while the promoter and enhancer 2 showed increasingly DNA methylation during CRC progression from adenomas to stage II and III CRC. Inhibition of DNA methylation rescued PTX3 expression in CRC. Finally, enhancer 1 acquired the binding of STAT3 in stage I CRC, and inhibition of STAT3 phosphorylation restored PTX3 activity and decreased enhancer 1 methylation. Thus, the expression of PTX3 is under the control of two enhancers, which emerge as important fine regulators of PTX3 expression in inflammation and cancer.

KW - Cancer

KW - DNA methylation

KW - enhancer

KW - inflammation

KW - pentraxin-3

UR - http://www.scopus.com/inward/record.url?scp=85023197440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023197440&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2017.1333215

DO - 10.1080/2162402X.2017.1333215

M3 - Article

AN - SCOPUS:85023197440

VL - 6

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 7

M1 - e1333215

ER -